All PlansAdministrativeLow impact
Voluntary nationwide recall: Clonazepam (Endo – July)
UPMC Health Plan·Pharmacy
We identified it
Jun 20, 2026
Summary
Endo USA recalled one lot of Clonazepam 0.25mg tablets due to incorrect labeling on cartons showing 0.125mg instead of 0.25mg, though blister strips show correct strength. This is a medication safety recall that may affect prescription dispensing and patient safety verification.
Action Required
Immediately: Alert providers and pharmacy staff about the Clonazepam recall for lot with incorrect carton labeling. Verify patients receiving 0.25mg Clonazepam from Endo USA are aware of correct dosing. Contact Inmar Inc. at 1-877-890-0765 for recall questions. No billing code changes required.